NCT00618267View on ClinicalTrials.gov

"ATP Expression in Lymphocytes of MS Patients by Means of ImmuKnow® Assay."

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Multiple Sclerosis
Trial Locations (1)

02445

Brigham and Women's Hospital - Partners MS Center, Brookline

Sponsors

Lead Sponsor

Biogen

Collaborators (1)

Elan Pharmaceuticals
All Listed Sponsors
collaborator

Elan Pharmaceuticals

INDUSTRY

lead

Biogen

INDUSTRY

NCT00618267 - "ATP Expression in Lymphocytes of MS Patients by Means of ImmuKnow® Assay." | Biotech Hunter | Biotech Hunter